It was reported that during continuous renal replacement therapy (crrt) using a prismaflex set and a prismaflex control unit, there was no blood flow observed in the extracorporeal circuit (ec).
It was reported the blood pump was running; however, no alarm was generated.
Treatment was terminated without returning the ec blood to the patient.
The blood loss was reported to 300ml.
No patient symptom was reported; however, the patient received a blood transfusion.
No additional information is available.
|
Additional information: upon follow up it was reported heparin was used as an anticoagulant (dose unknown).
It was reported a blood clot was noted at the access pod.
The actual device was not available; however, a video of the sample was provided for evaluation.
The video shows the y-connector, which is intended only for priming of the m100 set, was connected between the catheter and the access and return blood lines.
Per the prismaflex m100 instruction for use (ifu) the operator should "use the set by following the detailed on-line instructions provided by the prismaflex control unit".
After completion of the priming procedure, the prismaflex graphical user interface clearly states: "disconnect access line from y-line, connect to red luer lock on catheter (or other blood access)", i.
E.
The y-connector is not to be connected between the access line and the catheter as applicable for this event.
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.
Should additional relevant information become available, a supplemental report will be submitted.
|